Related Blog Posts

Big Pharma is not good for your health

19 hours ago ago from A World to Win

Swine flu is big business for pharmaceuticals like Roche, the manufacturer of the antiviral drug Tamiflu and the other giant corporations now producing vaccines to sell to desperate governments. Whether the products actually work is another matter and getting the trial data is nigh on impossible. Big Pharma is effectively a secret society that owes its gigantic profits to the National Health Service in Britain and its equivalent in other ...

Related content

Reimporting Drugs

8 hours ago ago from Booman Tribune

Getting back to that PhRMA deal that bars the reimportation of drugs... President Barack Obama still supports the re-importation of pharmaceuticals from other countries even though a deal he struck with the drug industry specifically excluded provisions on the controversial measure. Asked by The Hill on Tuesday if Obama backs the re-importation effort, White House press secretary Robert Gibbs said, ÂYes. The president said during the campaign ...

Related content

Another Call-Back, But She'll Take Brian's Resume!

1 hour, 36 minutes ago ago from Battling Pierre le Batarde

I had sent three resumes this morning, and within minutes got a call-back from a head-hunter working for a pharmaceutical company in Hillsdale! Ms. Rose Chu's ad had asked for someone with publishing experience, but that working within the pharmaceutical industry would be a definite plus. The position would be as an editorial liaison and quality control specialist between the pharmaceutical company and various publishers. Ms. Chu asked me if ...

Related content

Drug Development in the Balance The American, A Magazine of Ideas

10 hours ago ago from Business, Economics, Culture, and More — The American, A Magazine of Ideas

HOME ABOUT US ARCHIVE ADVERTISE CONTACT BLOG RSS FEED SEARCH AMERICAN.COM The Journal of the American Enterprise Institute ARTICLE TOOLS EMAIL A FRIEND EMAIL THE EDITOR PRINT SHARE BLOG COMMENTS Drug Development in the Balance By Jack Calfee Wednesday, December 9, 2009 Filed under: Health & Medicine , Boardroom , Government & Politics , Public Square , World Watch ...

Related content

Drug industry embraces new business strategies after tough year

8 hours ago ago from Technology, iPhone, Mobiles, Nokia, and Gadgets

As they pop the champagne corks to celebrate New Year's Eve, drug industry executives will likely be glad to put 2009 behind them. That's because pharmaceutical companies who make top-selling drugs for heart disease, asthma, and many other conditions had a tough year in the midst of mounting market pressures and a global recession. A timely year-end analysis of the state of the pharmaceutical industry is scheduled for the current issue of ...

Related content

Related News

Concert Pharmaceuticals Broadens Management Team and Expands Product Advisory Board

17 hours ago ago from Good News Now

Concert Pharmaceuticals, Inc. announced today the appointment of Lijun Wu, Ph.D., as Vice President, Biology. In this newly created position, Dr. Wu will have responsibility for Concert’s non-clinical pharmacology, pharmacokinetics, drug metabolism, and bioanalytical functions and will report to Roger Tung, Ph.D., President and Chief Executive Officer of Concert. Concert also announced today the addition of Lee Brettman, M.D. and Dennis ...

Related content

Fero Industries, Inc. Discloses Growth Through Acquisition Strategy

15 hours ago ago from Good News Now

Fero Industries, Inc. (OTCBB: FROI) (the “Company”), is pleased to disclose its growth strategy. FROI’s first acquisition target is Pyro Pharmaceuticals, Inc., a boutique developmental stage pharmaceutical company located in Irvine, CA. Pyro’s focus is on developing a new class of antibiotics to fight drug resistant bacteria, such as MRSA. Pyro has one issued and ten patents pending that protect a new class of antibiotics, geared towards ...

Related content

CyDex Pharmaceuticals Receives U.S. Patent for New Captisol®

16 hours ago ago from FanHouse

CyDex Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a patent to the company entitled “Sulfoalkyl Ether Cyclodextrin Compositions and Methods of Preparation Thereof.” This patent, along with other previously issued technology patents, will provide broader protection for CyDex’s Captisol ® technology until 2028. The patent (U.S. Patent No. 7,629,331) ...

Related content

Spectrum Pharmaceuticals Ranked among Orange County’s Top Work Places for 2009

18 hours ago ago from FanHouse

Spectrum Pharmaceuticals (NasdaqGM: SPPI), a commercial stage biotechnology company with a primary focus in oncology, today announced that it has been ranked by the Orange County Register as one of Orange County’s Top Work Places for 2009. “We are pleased to be recognized as one of the Top Work Places in Orange County,” said Rajesh C. Shrotriya, MD, Chairman, Chief Executive Officer, and President of Spectrum Pharmaceuticals. “We believe that ...

Related content

Absorption Systems Appoints Director of Scientific Operations

16 hours ago ago from FanHouse

Absorption Systems , a leader in testing drugs for ADMET (absorption, distribution, metabolism, excretion and toxicity), today announced that the company has hired Ramesh B. Bambal, Ph.D., as Director of Scientific Operations. Dr. Bambal joins Absorptions Systems with considerable pharmaceutical industry experience in drug discovery and preclinical development. While at Absorption Systems, Dr. Bambal will oversee drug discovery, business ...

Related content

Related Videos